SCHEMBL7988124

SCHEMBL7988124

CN(Cc1nc(=O)c2c(ncn2Cc2cccc(Cl)c2)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
GLA P06280 1/20 0.41
HTT P42858 1/20 0.41
UBE2N P61088 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
MAPK1 P28482 1/20 0.39
CACNA1G O43497 1/20 0.38
CACNA1B Q00975 1/20 0.38
CACNA1C Q13936 1/20 0.38
CNR2 P34972 3/20 0.38
YTHDC1 Q96MU7 2/20 0.37
PARN O95453 1/20 0.37
CNOT7 Q9UIV1 1/20 0.37
FSCN1 Q16658 1/20 0.36
RIPK1 Q13546 1/20 0.36
P2RX7 Q99572 3/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985460 0.91 CNOT7 (0.45) SMN1; SMN2HTR2CSLC6A4CACNA1GCACNA1B
SCHEMBL7988929 0.89 TP53 (0.43) HTR2CSLC6A4CACNA1GCACNA1BCACNA1C
SCHEMBL7987945 0.87 CACNA1G (0.39) SMN1; SMN2HTTHTR2CSLC6A4CACNA1G
SCHEMBL7988125 0.86 HPGD (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974301 0.86 CACNA1G (0.40) SMN1; SMN2HTTHTR2CSLC6A4CACNA1G
SCHEMBL7992288 0.86 ABCC8 (0.41) HTR2CSLC6A4CACNA1GCACNA1BCACNA1C
SCHEMBL7988921 0.82 CNOT7 (0.44) SMN1; SMN2HTR2CSLC6A4PARNCNOT7
SCHEMBL7991608 0.82 CNOT7 (0.47) HTR2CSLC6A4MAPK1CACNA1GCACNA1B
SCHEMBL7975225 0.82 CACNA1G (0.40) HTR2CSLC6A4CACNA1GCACNA1BCACNA1C
SCHEMBL7974180 0.81 CNOT7 (0.44) SMN1; SMN2HTR2CSLC6A4PARNCNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed